p53 Protein Expression in Grade II Astrocytomas: Immunohistochemical Study of 100 Cases with Long-Term Follow-Up
- 31 December 1998
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 194 (12) , 831-836
- https://doi.org/10.1016/s0344-0338(98)80085-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Aberrant p53 Expression Does Not Correlate with the Prognosis in Anaplastic AstrocytomaNeurosurgery, 1995
- p53 immunoreactivity in astrocytomas and its relationship to survivalBritish Journal Of Neurosurgery, 1995
- Prognostic Implications of p53 Overexpression in Supratentorial Astrocytic TumorsNeurosurgery, 1994
- p53 protein in low-grade astrocytomas: a study with long-term follow-upBritish Journal of Cancer, 1994
- Pattern of mutant p53 expression in human astrocytomas suggests the existence of alternate pathways of tumorigenesisCancer, 1994
- p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodiesActa Neuropathologica, 1993
- Expression of the p53 protein in a spectrum of astrocytic tumoursThe Journal of Pathology, 1992
- Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumoursBritish Journal of Cancer, 1992
- p53 protein expression in central nervous system neoplasms.Journal of Clinical Pathology, 1992